BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12754289)

  • 1. Patterns of MUC1 tissue expression defined by an anti-MUC1 cytoplasmic tail monoclonal antibody in breast cancer.
    Croce MV; Isla-Larrain MT; Rua CE; Rabassa ME; Gendler SJ; Segal-Eiras A
    J Histochem Cytochem; 2003 Jun; 51(6):781-8. PubMed ID: 12754289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC1 cytoplasmic tail detection using CT33 polyclonal and CT2 monoclonal antibodies in breast and colorectal tissue.
    Croce MV; Isla-Larrain M; Remes-Lenicov F; Colussi AG; Lacunza E; Kim KC; Gendler SJ; Segal-Eiras A
    Histol Histopathol; 2006 Aug; 21(8):849-55. PubMed ID: 16691537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue and serum MUC1 mucin detection in breast cancer patients.
    Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear localization of MUC1 extracellular domain in breast, head and neck, and colon cancer.
    Rabassa ME; Larrain MT; Lacunza E; Cermignani L; Alberdi CG; Demichelis SO; Abba MC; Segal-Eiras A; Croce MV
    Int J Biol Markers; 2015 Jul; 30(3):e294-300. PubMed ID: 25982681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
    Tamura Y; Higashi M; Kitamoto S; Yokoyama S; Osako M; Horinouchi M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
    PLoS One; 2012; 7(11):e49251. PubMed ID: 23152882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
    Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E
    Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
    Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
    J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach.
    Yonezawa S; Kitajima S; Higashi M; Osako M; Horinouchi M; Yokoyama S; Kitamoto S; Yamada N; Tamura Y; Shimizu T; Tabata M; Goto M
    Gastric Cancer; 2012 Oct; 15(4):370-81. PubMed ID: 22237656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sialic acid removal on MUC1 antigenic reactivity in head and neck carcinoma.
    Croce MV; Rabassa ME; Pereyra A; Segal-Eiras A
    Pathol Oncol Res; 2005; 11(2):74-81. PubMed ID: 15999150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
    Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
    Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
    Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
    [No Abstract]   [Full Text] [Related]  

  • 12. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
    Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
    BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.
    Heublein S; Mayr D; Egger M; Karsten U; Goletz S; Angele M; Gallwas J; Jeschke U; Ditsch N
    J Exp Clin Cancer Res; 2015 May; 34(1):50. PubMed ID: 25986064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.
    Gold DV; Karanjawala Z; Modrak DE; Goldenberg DM; Hruban RH
    Clin Cancer Res; 2007 Dec; 13(24):7380-7. PubMed ID: 18094420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.
    Lavrsen K; Madsen CB; Rasch MG; Woetmann A; Ødum N; Mandel U; Clausen H; Pedersen AE; Wandall HH
    Glycoconj J; 2013 Apr; 30(3):227-36. PubMed ID: 22878593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune response against tumoral mucin 1 (MUC1) in breast cancer patients.
    Isla Larrain MT; Colussi AG; Demichelis SO; Barbera A; Cretón A; Segal-Eiras A; Croce MV
    Int J Biol Markers; 2013 Sep; 28(3):318-25. PubMed ID: 23828406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunohistochemical study of MUC1 and carbohydrate antigens in breast benign disease and normal mammary gland.
    Demichelis SO; Alberdi CG; Servi WJ; Isla-Larrain MT; Segal-Eiras A; Croce MV
    Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):41-50. PubMed ID: 19625949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer.
    Wang L; Chen H; Liu F; Madigan MC; Power CA; Hao J; Patterson KI; Pourgholami MH; O'Brien PM; Perkins AC; Li Y
    Cancer Lett; 2011 Jan; 300(2):122-33. PubMed ID: 21075513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.